S. 1302

Status: In committee

Increasing Transparency in Generic Drug Applications Act

Increasing Transparency in Generic Drug Applications Act

Sponsored by Margaret Wood Hassan (Democrat-NH)

Topics

Cosponsors

6

Actions

2

Roll calls

0

Amendments

0

Related bills

4

Actions

Apr 3, 2025 · Library of Congress

Introduced in Senate

Apr 3, 2025 · Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Latest activity

July 2026

Lobbying reported · Biotechnology Innovation Organization · Jul 21

Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000

Lobbying reported · Blue Cross And Blue Shield Of Florida · Jul 20

Blue Cross And Blue Shield Of Florida reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Of Florida — $80,000

Lobbying reported · Blue Cross And Blue Shield Association · Jul 20

Blue Cross And Blue Shield Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Association — $990,000

Lobbying reported · Guidewell Mutual Holding · Jul 20

Guidewell Mutual Holding reported 2nd Quarter (Apr 1 - June 30) lobbying for Guidewell Mutual Holding — $20,000

Lobbying reported · Blue Cross Blue Shield Of Michigan · Jul 20

Blue Cross Blue Shield Of Michigan reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross Blue Shield Of Michigan — $276,347

Lobbying reported · Bcbsm · Jul 17

Bcbsm reported 2nd Quarter (Apr 1 - June 30) lobbying for Bcbsm — $28,000

BillsH.R. 1 H.R. 1197 H.R. 1627 H.R. 1843 H.R. 1909 H.R. 2509 H.R. 3841 H.R. 4570 H.R. 4710 H.R. 5629 H.R. 6248 S. 931 S. 958 S. 1040 S. 1041 S. 1096 S. 1302 S. 1954 S. 2355 S. 2658 S. 3014 S. 4027

Lobbying reported · Mehlman Consulting · Jul 17

Mehlman Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for Association Of Accessible Medicines — $60,000

BillsH.R. 1843 H.R. 3269 H.R. 5526 S. 43 S. 1040 S. 1302 S. 1954

Lobbying reported · S-3 Group · Jul 17

S-3 Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Viatris — $60,000

BillsH.R. 1843 S. 527 S. 1041 S. 1096 S. 1302

Lobbying reported · College of American Pathologists (CAP) · Jul 15

College of American Pathologists (CAP) reported 2nd Quarter (Apr 1 - June 30) lobbying for College of American Pathologists (CAP) — $180,107

Lobbying reported · Blue Cross And Blue Shield Of Kansas · Jul 14

Blue Cross And Blue Shield Of Kansas reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Of Kansas — $10,000

BillsH.R. 668 H.R. 1227 H.R. 1627 H.R. 1843 H.R. 1909 H.R. 2509 H.R. 3841 H.R. 4077 H.R. 4710 H.R. 5629 H.R. 5746 H.R. 6248 H.R. 7324 S. 1040 S. 1041 S. 1096 S. 1302 S. 1954 S. 2355 S. 2658 S. 3014 S. 4027

Lobbying reported · Holland & Knight · Jul 13

Holland & Knight reported 2nd Quarter (Apr 1 - June 30) lobbying for Viatris — $50,000

You’re all caught up.